HAO:NSD-Haoxi Health Technology Limited Class A Ordinary Shares (USD)

COMMON STOCK | Advertising Agencies |

Last Closing

USD 1.3874

Change

-0.05 (-3.70)%

Market Cap

N/A

Volume

945.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-05 )

Largest Industry Peers for Advertising Agencies

Symbol Name Price(Change) Market Cap
TTD Trade Desk Inc

-4.94 (-6.50%)

USD 36.97B
ADVWW Advantage Solutions Inc

N/A

USD 3.69B
MGNI Magnite Inc

+0.78 (+4.68%)

USD 2.17B
CRTO Criteo Sa

-0.61 (-2.27%)

USD 1.35B
ZD Ziff Davis Inc

+0.12 (+0.37%)

USD 1.30B
IAS Integral Ad Science Holding LL..

+0.08 (+0.98%)

USD 1.29B
STGW Stagwell Inc

+0.02 (+0.47%)

USD 1.26B
QNST QuinStreet Inc

+0.06 (+0.39%)

USD 0.84B
NEXN Nexxen International Ltd

-0.19 (-1.73%)

USD 0.74B
NCMI National CineMedia Inc

-0.01 (-0.20%)

USD 0.48B

ETFs Containing HAO

N/A

Market Performance

  Market Performance vs. Industry/Classification (Advertising Agencies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -60.86% 13% F 7% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return -60.86% 13% F 7% C-
Trailing 12 Months  
Capital Gain -99.18% 3% F 1% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.18% 3% F 1% F
Trailing 5 Years  
Capital Gain -99.78% 7% C- 2% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.78% 7% C- 2% F
Average Annual (5 Year Horizon)  
Capital Gain -18.57% 32% F 16% F
Dividend Return -18.57% 32% F 15% F
Total Return N/A 50% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 36.43% 68% D+ 49% F
Risk Adjusted Return -50.98% 36% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.